Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001704890 | SCV000236763 | likely benign | not provided | 2020-10-19 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000467045 | SCV000542727 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-03-16 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000184146 | SCV000597652 | uncertain significance | not specified | 2016-06-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002444747 | SCV002734980 | likely benign | Cardiovascular phenotype | 2020-09-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV001704890 | SCV003824846 | uncertain significance | not provided | 2023-02-05 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003486744 | SCV004239932 | likely benign | Cardiomyopathy | 2023-01-10 | criteria provided, single submitter | clinical testing |